Healthcare

AI-Powered Lung Disease Diagnosis Achieves 96.57% Accuracy

January 24, 2025 03:26 PM AEDT| By Team Kalkine Media

Highlights:,AI model achieves 96.57% accuracy in diagnosing respiratory diseases through lung ultrasound analysis.,The model provides visual explanations to enhance radiologists' trust and decision-making.,Potential applications include detecting con...

Clarity Pharmaceuticals (ASX:CU6) Gains FDA Fast Track Status for PET Scan Imaging Agent

January 24, 2025 03:00 PM AEDT| By Team Kalkine Media

Highlights,Clarity Pharmaceuticals (ASX:CU6) secures FDA fast-track designation for its Cu-64 SAR-,bisPSMA,imaging agent targeting recurrent prostate cancer.,The company's market capitalization surpasses $1 billion, reflecting investor confidence ami...

4DMedical (ASX:4DX) Expands Commercial Presence with Qscan Radiology Clinics Agreement

January 24, 2025 02:02 PM AEDT| By Team Kalkine Media

Highlight:,4DMedical Ltd (ASX:4DX) secures a commercial agreement with,Qscan,Radiology Clinics for lung health assessment products.,The agreement marks the first commercial contract in Australia to feature the Pulmonary Function and Pulmonary Structu...

Clarity Pharmaceuticals (ASX: CU6) Rises 3.5% on FDA Fast Track Designation for 64Cu-SAR-bisPSMA

January 24, 2025 01:52 PM AEDT| By Team Kalkine Media

Highlights,Clarity Pharmaceuticals (ASX:CU6) share price up 3.5%, reaching AUD 4.20.,FDA grants Fast Track Designation for 64Cu-SAR-bisPSMA in prostate cancer imaging.,This milestone marks a significant step forward in Clarity's bisPSMA program.,In t...

Are ASX Healthcare Stocks Showing a New Trend?

January 24, 2025 11:00 AM AEDT| By Team Kalkine Media

Highlights,ASX health sector has recorded a modest upward trend with diverse share price fluctuations across various companies.,EBR Systems achieves a regulatory milestone through an FDA manufacturing pre-approval inspection and entry into the TCET r...

We believe that Clarity Pharmaceuticals (ASX:CU6) is well-positioned financially to support its business growth.

January 24, 2025 09:30 AM AEDT| By Team Kalkine Media

Exploring Clarity Pharmaceuticals' Cash Position

Dusk Group Tops the List of 3 ASX Penny Stocks

January 23, 2025 05:26 PM AEDT| By Team Kalkine Media

Boosted Optimism as ASX200 Reaches New Highs

ASX Stocks Potentially Undervalued in January 2025

January 23, 2025 05:26 PM AEDT| By Team Kalkine Media

Australian Stock Market's Positive Swing and Undervalued Opportunities

MedAdvisor (ASX:MDR) shares have fallen 66% in five years, losing AU$14 million last week.

January 23, 2025 05:23 PM AEDT| By Team Kalkine Media

Analyzing MedAdvisor's (ASX:MDR) Journey: A Look at Long-Term Investment Insights

Shares of Nanosonics Limited (ASX:NAN) Might Be Trading at 24% Below Their Estimated Intrinsic Value

January 23, 2025 05:23 PM AEDT| By Team Kalkine Media

Nanosonics Limited (ASX:NAN) Valuation Analysis

Potential for Additional Gains in SomnoMed Limited (ASX:SOM) Shares May Present Price Risks Following a 27% Surge

January 23, 2025 05:21 PM AEDT| By Team Kalkine Media

SomnoMed (ASX:SOM) Stock on the Rise: A Closer Look at Its Market Metrics

Health Check: Once a minor player, Nanosonics now dominates the field.

January 23, 2025 11:00 AM AEDT| By Team Kalkine Media

Nanosonics Signals Strong Financial Growth Amid Biotech Developments

Botanix Pharmaceuticals Reaches a Significant Milestone with Long Shortz

January 23, 2025 11:00 AM AEDT| By Team Kalkine Media

Highlights:,Botanix Pharmaceuticals (BOT) secures a position in the ASX 300, reinforcing its growth trajectory.,The company remains dedicated to advancing dermatological treatments through ongoing research.,Development efforts focus on addressing pri...

Orthocell Ltd's (ASX:OCC) Global Expansion Strategy Gains Momentum with Strong Sales Growth for Remplir™

January 22, 2025 12:36 PM AEDT| By Team Kalkine Media

Highlights,Orthocell,Ltd (,ASX:OCC,) expands,Remplir,™ into global markets, backed by strong sales growth.,The US market opportunity,valued,at ~US,$1.6 billion,per year.,Anticipated FDA clearance for,Remplir,™ set for March/April 2025.,Orthocell Ltd...

Compumedics Secures 5-Year Philips Contract for Somfit Sleep Device, Expands U.S. Market Presence

January 22, 2025 12:10 PM AEDT| By Team Kalkine Media

Highlights,New 5-Year Agreement with Philips:,Compumedics will continue supplying its,Somfit device,to Philips' pharmacy-based sleep program in Australia through 2028, solidifying its position in the rapidly growing pharmacy-based sleep testing marke...